Extracellular Vesicles Engineering & Their Roles as Carrier of Therapeutics Agents

Time: 2:30 pm
day: Pre-Conference Focus Day


  • Using EVs targeting cancer cells and human placenta which can be beneficial for women with placenta deficiencies during pregnancies
  • How to scale up the production of EVs
  • Scaling up a variation of different batch of EVs and certain quality control GMP conditions
  • How to modify targeting of EVs
  • How to incorporate molecules inside of EVs. Fusing with lipid or synthetic nanoparticles